In vivo biodistribution study of TAT-L-Sco2 fusion protein, developed as protein therapeutic for mitochondrial disorders attributed to SCO2 mutations.
Mol Genet Metab Rep
; 25: 100683, 2020 Dec.
Article
em En
| MEDLINE
| ID: mdl-33318931
99mTc, Technetium-99 m.; BSA, Bovine Serum Albumin;; COX, Cytochrome c oxidase;; FBS, Fetal bovine serum;; IBs, Inclusion bodies;; ID, Injected dose;; PBS, Phosphate buffered saline;; PRT, Protein Replacement Therapy;; PTD, Protein Transduction Domain;; RA, Radioactivity;; RT, Room Temperature;; SD, Standard Deviation;; SEC, Size Exclusion Chromatography;; TAT-L-Sco2, 10xHis-XaSITE-TAT-L-Sco2-HA;; i.p., Intraperitoneal;; i.v., Intravenous;; l-Arg, l-Arginine;; p.i., Post-injection;
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Mol Genet Metab Rep
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Grécia